Healthline: Rates of IBD including Crohn’s Disease are three times higher than realized

UC digestive diseases expert discusses treatment options

A journalist for Healthline spoke with Loren Brook, MD, an assistant professor in the UC Department of Internal Medicine, about possible treatments for inflammatory bowel disease (IBD). In 2015, more than 3 million U.S. adults reported a diagnosis of IBD, an ongoing inflammation of all or part of the digestive tract, and includes two conditions,   Crohn’s Disease and ulcerative colitis.

Brook, also a UC Health physician, explained the disease is usually lifelong but can be managed with relatively minor anti-inflammatory drugs such as oral mesalamine to immune-suppressing medications such as Remicade or steroids.

View the Heathline report online.

Related Stories

1

A partnership to end pancreatic cancer

December 19, 2025

Since 2010, BSI Engineering has raised more than $1.2 million for pancreatic cancer research at the University of Cincinnati Cancer Center in honor of a friend and inspiration to BSI’s founders, Bryan Speicher.